These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 4380598)

  • 1. Comparison of some properties of pronethalol and propranolol.
    Black JW; Duncan WA; Shanks RG
    Br J Pharmacol Chemother; 1965 Dec; 25(3):577-91. PubMed ID: 4380598
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of sympathetic beta-receptor blockade by recording the rate of ventricular pressure rise in cats.
    Benfey BG; Greeff K; Heeg E
    Br J Pharmacol Chemother; 1967 May; 30(1):23-9. PubMed ID: 4382675
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of ICI 50172, propranolol, pronethalol and MJ 1999 on beta-receptors.
    Wale J; Pun LQ; Rand MJ
    Eur J Pharmacol; 1969 Oct; 8(1):25-35. PubMed ID: 4391044
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of dichloro-isoproterenol, pronethalol and propranolol on arterial pressure of the amyelic dog and on the rate of the enervated heart].
    Duchêne-Marullaz P; Delort P; Rispat G; Cosnier D
    C R Seances Soc Biol Fil; 1966; 160(8):1600-4. PubMed ID: 4383096
    [No Abstract]   [Full Text] [Related]  

  • 5. The pharmacology of beta sympathetic blockade.
    Shanks RG
    Am J Cardiol; 1966 Sep; 18(3):308-16. PubMed ID: 4380735
    [No Abstract]   [Full Text] [Related]  

  • 6. On the blood content of guinea-pig tissues.
    Bosse JA; Wassermann O
    Pharmacology; 1970; 4(5):273-7. PubMed ID: 5490474
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological properties of tetrahydropapaveroline.
    Santi R; Ferrari M; Tóth CE; Contessa AR; Fassina G; Bruni A; Luciani S
    J Pharm Pharmacol; 1967 Jan; 19(1):45-51. PubMed ID: 4382174
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta adrenergic blocking and cardiovascular properties of two new substances, Kö 1313 and Kö 1366.
    Baum T; Rowles G; Shropshire AT; Gluckman MI
    J Pharmacol Exp Ther; 1971 Feb; 176(2):339-49. PubMed ID: 4398186
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of some properties of pronethalol and propranolol. 1965.
    Black JW; Duncan WA; Shanks RG
    Br J Pharmacol; 1997 Feb; 120(4 Suppl):285-99; discussion 283-4. PubMed ID: 9142411
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective blockade of adrenoceptive beta receptors in the heart.
    Dunlop D; Shanks RG
    Br J Pharmacol Chemother; 1968 Jan; 32(1):201-18. PubMed ID: 4384337
    [No Abstract]   [Full Text] [Related]  

  • 11. Some pharmacological properties of a new adrenergic beta-receptor antagonist.
    Shanks RG; Wood TM; Dornhorst AC; Clark ML
    Nature; 1966 Oct; 212(5057):88-90. PubMed ID: 4381648
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of corticosteroid levels in animal organs and tissues].
    Fazekas AT; Fazekas IG
    Endokrinologie; 1971 Dec; 58(3):301-25. PubMed ID: 5168968
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-adrenoreceptor blocking properties of new thienylethanolamine derivatives.
    Darias V; Madroñero R; del Río J
    Arzneimittelforschung; 1974 Nov; 24(11):1751-6. PubMed ID: 4155632
    [No Abstract]   [Full Text] [Related]  

  • 14. The distribution of gamma-L-glutamyl-L-glutamine in mammalian tissues.
    Kanazawa A; Sano I
    J Neurochem; 1967 May; 14(5):596-8. PubMed ID: 6025631
    [No Abstract]   [Full Text] [Related]  

  • 15. Adrenergic receptors on some organs.
    Takagi K; Osada E; Takayanagi I; Taga F
    Arch Int Pharmacodyn Ther; 1967 Jul; 168(1):212-9. PubMed ID: 4383015
    [No Abstract]   [Full Text] [Related]  

  • 16. Tissue and subcellular distribution of mammalian aldehyde-oxydizing capacity.
    Deitrich RA
    Biochem Pharmacol; 1966 Dec; 15(12):1911-22. PubMed ID: 4291564
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparison of the adrenergic receptor blocking properties of 1-(4'-methylphenyl)-2-isopropylamino-propanol-HCl and propranolol.
    Levy B
    J Pharmacol Exp Ther; 1967 Jun; 156(3):452-62. PubMed ID: 6067476
    [No Abstract]   [Full Text] [Related]  

  • 18. Antisympathomimetic and antifibrillatory effects of pronethalol and propranolol.
    Benfey BG; Varma DR
    Br J Pharmacol Chemother; 1966 Jan; 26(1):3-8. PubMed ID: 4380639
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of propranolol on the peripheral vascular bed.
    Nakano J; Kusakari T
    Nature; 1966 Feb; 209(5026):923-4. PubMed ID: 5922798
    [No Abstract]   [Full Text] [Related]  

  • 20. Quinterenol, a new beta adrenergic stimulant.
    Scriabine A; Moore PF; Iorio LC; Goldman IM; McShane WK; Booher KD
    J Pharmacol Exp Ther; 1968 Jul; 162(1):60-9. PubMed ID: 4385348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.